{
  "docId": "019de075-b6c3-715f-bed8-4c3a534b1fd4",
  "docSlug": "88f1b85a63c225232d32e053da178119",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 25 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 25,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "timeline",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-b6c3-715f-bed8-4c3a534b1fd4/16",
  "deckHref": "/decks/019de075-b6c3-715f-bed8-4c3a534b1fd4",
  "deckJsonHref": "/decks/019de075-b6c3-715f-bed8-4c3a534b1fd4.json",
  "deckAnchorHref": "/decks/019de075-b6c3-715f-bed8-4c3a534b1fd4#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.92,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Timeline showing 2023 and Late 2023-2025 milestones",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e3848e4c-1a8a-428a-914f-c6d501827cfa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.38,
        "x": 0.1,
        "y": 0.415
      },
      "kind": "list",
      "text": "Ongoing trials: eAArly DETECT (US) - 450 subjects, 25 sites; ColoFuture (Germany & Norway) - 662 subjects, 9 sites",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64b97f2a-1ea5-481f-b843-81c17dae6c8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.38,
        "x": 0.55,
        "y": 0.415
      },
      "kind": "list",
      "text": "Launched trials: ReconAAsense (US) - Pivotal FDA PMA study, ~15,000 subjects, 150 sites",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8cc2524b-5779-4129-9de3-f40fbcf93920",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.083,
        "w": 0.599,
        "x": 0.048,
        "y": 0.035
      },
      "kind": "title",
      "text": "Next Generation Clinical Validation and Trials",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d252443-ef78-4d47-8a2c-5e4a129b049d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "d9c2e816-4e60-4605-8e1e-64c290685734",
      "evidence": "Chronological progression of clinical trials",
      "confidence": 1
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 25,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "82aba536-6cfb-4714-9432-b52a39ec7273",
      "evidence": "WHY (CRC need), HOW (innovative tests), WHAT (investment ask)",
      "position": 1,
      "objective": "Presenting a compelling investment opportunity",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}